Xiao‐En Xu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer-related molecular mechanisms research 7
- Cancer Genomics and Diagnostics 4
- Oncology 11
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
Xiao‐En Xu
28 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 647
- Oncology 354
- Molecular Biology 815
- Pulmonary and Respiratory Medicine 187
- Immunology 117
Countries citing papers authored by Xiao‐En Xu
This map shows the geographic impact of Xiao‐En Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐En Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐En Xu more than expected).
Fields of papers citing papers by Xiao‐En Xu
This network shows the impact of papers produced by Xiao‐En Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐En Xu. The network helps show where Xiao‐En Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao‐En Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 62 | |
| 4 | 2021 | 41 | |
| 5 | 2020 | 18 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 70 | |
| 8 | 2020 | 32 | |
| 9 | 2019 | 96 | |
| 10 | 2016 | 71 | |
| 11 | 2016 | 157 | |
| 12 | 2016 | 175 | |
| 13 | 2016 | 62 | |
| 14 | 2015 | 20 | |
| 15 | 2014 | 5 | |
| 16 | 2014 | 34 | |
| 17 | 2013 | 33 | |
| 18 | 2012 | 15 | |
| 19 | 2010 | 54 | |
| 20 | 2010 | 110 |
About Xiao‐En Xu
Xiao‐En Xu is a scholar working on Cancer Research, Oncology, Biological Psychiatry, Genetics and Molecular Biology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (4 papers), RNA Research and Splicing (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Peptidase Inhibition and Analysis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (647 citations), Oncology (354 citations), Molecular Biology (815 citations), Pulmonary and Respiratory Medicine (187 citations) and Immunology (117 citations). Xiao‐En Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Xi Jin, Ke‐Da Yu, Yi-Zhou Jiang, Yi‐Rong Liu, Zhi‐Ming Shao, Zhi-Ming Shao, Da‐Qiang Li, Xin Hu, Yi‐Zhou Jiang and Xin Hu. Their work appears in journals such as Clinical Cancer Research, Theranostics, Tumor Biology, Journal of Proteomics and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.